Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Capital Expenditures (2020 - 2026)

Maxcyte has reported Capital Expenditures over the past 6 years, most recently at $1.7 million for Q4 2025.

  • Quarterly Capital Expenditures rose 7.61% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 7.09% year-over-year, with the annual reading at $1.8 million for FY2025, 7.09% up from the prior year.
  • Capital Expenditures was $1.7 million for Q4 2025 at Maxcyte, up from -$62000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $12.8 million in Q2 2022 and troughed at -$15.9 million in Q4 2022.
  • The 5-year median for Capital Expenditures is $53600.0 (2022), against an average of $232220.0.
  • Year-over-year, Capital Expenditures plummeted 11275.57% in 2022 and then surged 3981.25% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $142450.0 in 2021, then plummeted by 11275.57% to -$15.9 million in 2022, then skyrocketed by 101.75% to $279000.0 in 2023, then skyrocketed by 479.21% to $1.6 million in 2024, then grew by 7.61% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Capital Expenditures are $1.7 million (Q4 2025), -$62000.0 (Q3 2025), and -$562000.0 (Q2 2025).